Skip to main content
Label-Free Detection (LFD) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, China, UK, France - Size and Forecast 2024-2028

Label-Free Detection (LFD) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, China, UK, France - Size and Forecast 2024-2028

Published: Oct 2024 165 Pages SKU: IRTNTR74641

Market Overview at a Glance

$324.8 Mn
Market Opportunity
7.1%
CAGR
6.5
YoY growth 2023-2024(%)

Label-Free Detection (LFD) Market Size 2024-2028

The label-free detection (lfd) market size is forecast to increase by USD 324.8 million at a CAGR of 7.1% between 2023 and 2028.

  • Label-Free Detection Market Insights and Trends the market is experiencing significant growth due to several key trends. The rise in drug discovery programs is driving market demand, as LFD techniques offer advantages such as increased sensitivity, reduced sample preparation time, and real-time analysis. Additionally, the market is witnessing an increase in new product launches, as companies seek to combine sensitivity and throughput into a single system. These advancements are revolutionizing various industries, including life sciences, food and beverage, and environmental monitoring. The LFD market is expected to continue its growth trajectory, offering numerous opportunities for stakeholders.

    • What will be the Size of the Label-Free Detection (LFD) Market During the Forecast Period?

    Label-Free Detection (LFD) Market Size

     Request Free Sample

  • The market encompasses technologies that enable the analysis of biomolecular interactions and biomarker discovery without the use of labels or tags. This market holds significant importance in various sectors, including drug discovery, biotechnology, applied chemistry, and biological sciences. Real-time analysis is a key trend in LFD, as it offers advantages such as increased sensitivity and faster results. Technologies such as Surface Plasmon Resonance (SPR), Isothermal Titration Calorimetry (ITC), and Mass Spectrometry (MS) are prominent In the LFD market. These techniques facilitate the study of binding kinetics, RNA detection, and biomolecular interactions, among others. The market is also witnessing growth in areas like clinical trials, high-throughput screening, and personalized medicine.
  • Native proteins and their ligands are primary targets for LFD, with applications ranging from biopharmaceutical development to on-chip purification. Optical methods and differential scanning calorimetry are additional techniques contributing to the market's expansion. The LFD market's potential lies in its ability to provide valuable insights into various aspects of biology and chemistry, ultimately contributing to advancements in healthcare and industry.

    • How is this Label-Free Detection (LFD) Industry segmented and which is the largest segment?

    The label-free detection (lfd) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

    • End-user
      • Pharmaceutical and biotechnology companies
      • Contract research organizations (CROs)
      • Academic and research institutes
    • Product
      • Biochemical assays
      • Cell-based assays
    • Geography
      • North America
        • US
      • Europe
        • Germany
        • UK
        • France
      • Asia
        • China
      • Rest of World (ROW)

      By End-user Insights

      • The pharmaceutical and biotechnology companies segment is estimated to witness significant growth during the forecast period.

      The market experiences significant growth due to its extensive application in pharmaceutical and biotechnology industries. Pharmaceutical and biopharmaceutical companies utilize LFD techniques for drug discovery and product development. Biomolecular interactions, such as binding kinetics, are crucial in understanding the mechanism of action of drug molecules. LFD methods, including optical techniques like refractive index (RI) and surface plasmon resonance (SPR), and advanced technologies such as isothermal titration calorimetry (ITC), facilitate the analysis of these interactions in real-time. These techniques enable high-throughput screening, biomarker discovery, and on-chip purification, streamlining the biopharmaceutical development process. LFD is also instrumental in personalized medicine, molecular interactions, and therapeutic targets identification.

      Clinical research and clinical trials benefit from LFD's ability to detect native proteins, ligands, RNA, and miRNA. The increasing healthcare expenditure on chronic diseases and the demand for analytical solutions In the pharmaceutical, clinical research, and life sciences sectors further fuel the market's growth.

      Label-Free Detection (LFD) Market Size

      Get a glance at the  Label-Free Detection (LFD) Industry report of share of various segments Request Free Sample

      The Pharmaceutical and biotechnology companies segment was valued at USD 376.90 million in 2018 and showed a gradual increase during the forecast period.

      Regional Analysis

      • North America is estimated to contribute 36% to the growth of the global market during the forecast period.

      Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

      Label-Free Detection (LFD) Market Share by Geography

      For more insights on the market share of various regions, Request Free Sample

      The market in North America is experiencing significant growth due to several key factors. Pharmaceutical and biopharmaceutical companies' increasing investments in research and development for drug discovery, favorable government funding, and technological advancements are driving market expansion. The presence of numerous pharmaceutical and life sciences companies In the region increases the availability of drug molecules for various therapeutic applications. These companies focus on developing new techniques for detecting viral diseases, enhancing their product offerings, and expanding their customer base. Technological innovations in LFD, such as optical methods, real-time analysis, and on-chip purification, contribute to the market's growth. Key techniques, including surface plasmon resonance, isothermal titration calorimetry, and mass spectrometry, are used for biomolecular interactions, drug screening, and biomarker discovery.

      The increasing prevalence of chronic diseases and healthcare expenditure further boosts the market's growth. Contract research organizations (CROs) play a crucial role in providing analytical solutions and clinical research services, enabling the pharmaceutical industry to focus on drug development. The market's sensitivity, as demonstrated by techniques like RNA detection and miRNA detection, is a significant advantage for personalized medicine and therapeutic targets in proteomics, genomics, and single-cell analysis.

      Market Dynamics

      Our  researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

      What are the key market drivers leading to the rise In the adoption of Label-Free Detection (LFD) Industry?

      Rise in drug discovery programs is the key driver of the market.

    • The market is experiencing significant growth due to the increasing demand for real-time analysis and high-throughput screening in drug discovery and biotechnology. Applications of LFD in biomedical research, clinical research, and pharmaceutical development have been expanding, particularly In the areas of biomolecular interactions, biomarker discovery, and therapeutic targets. Technologies such as Surface Plasmon Resonance (SPR), Isothermal Titration Calorimetry (ITC), and Mass Spectrometry (MS) are commonly used for label-free detection. These methods enable the study of binding kinetics, signal enhancement, and on-chip purification, providing valuable insights into molecular interactions. Contract research organizations (CROs) play a crucial role In the market by offering analytical solutions to biopharmaceutical companies.
    • The increasing healthcare expenditure on chronic diseases, such as respiratory diseases, chronic kidney diseases, and leukemia, drives the demand for label-free detection in drug screening and personalized medicine. Additionally, advancements in optical methods, RNA detection, and single-cell analysis are expected to further fuel the growth of the market. The sensitivity of label-free detection methods, such as refractive index (RI) and AuNPs, allows for the detection of native proteins, ligands, and biomolecules, making it an essential tool in biopharmaceutical development.

      • What are the market trends shaping the Label-Free Detection (LFD) Industry?

      New product launches is the upcoming market trend.

    • The market is experiencing significant growth due to its increasing application in various sectors, particularly in drug discovery and biotechnology. Applied chemistry and biological sciences are leveraging LFD for real-time analysis of biomolecular interactions, binding kinetics, and biomarker discovery. Optical methods, including Surface Plasmon Resonance (SPR) and Isothermal Titration Calorimetry (ITC), are popular techniques used in LFD. Pharmaceutical and biopharmaceutical companies, clinical research organizations (CROs), and healthcare institutions are the primary end-users of LFD technology. The demand for LFD is driven by the need for analytical solutions to enhance signal and detect native proteins, ligands, and biomolecular interactions. Recent advancements in LFD technology include the launch of new systems, such as Bruker Corp.'s
    • timsTOF MALDI PharmaPulse, which utilizes label-free mass spectrometry for deep high-throughput screening. This trend is expected to continue, as companies introduce new LFD systems to cater to the increasing demand from various industries. Moreover, LFD is also used In the detection of RNA and miRNA, which is crucial in chronic disease research and personalized medicine. The market for LFD is further expected to grow due to its application in on-chip purification, biopharmaceutical development, and single-cell analysis. In conclusion, the LFD market is witnessing significant growth due to its application in various sectors, including drug discovery, biotechnology, and healthcare.
    • The increasing demand for LFD systems and the launch of new products by companies are expected to drive the growth of the market during the forecast period.

      • What challenges does the Label-Free Detection (LFD) Industry face during its growth?

      Combining sensitivity and throughput into single system is a key challenge affecting the industry growth.

    • The market In the US is driven by the increasing demand for real-time analysis and high-throughput screening in drug discovery and biotechnology. Applications of LFD span across various sectors, including biological sciences, pharmaceutical, and clinical research. The market is characterized by the use of advanced technologies such as optical methods, surface plasmon resonance (SPR), and isothermal titration calorimetry (ITC), among others. These techniques enable the detection of biomolecular interactions, binding kinetics, and biomarker discovery with high sensitivity. Despite the advantages of LFD, challenges persist. The integration of sensitivity and high-throughput remains a significant hurdle for companies. Thousands of samples are analyzed daily, necessitating automation and skilled professionals to handle complex systems.
    • Contamination risks are minimized with integrated systems, while compatibility issues arise when using consumables and instruments from different companies. LFD is particularly valuable In the biopharmaceutical sector for drug screening, on-chip purification, and biopharmaceutical development. In addition, it plays a crucial role in personalized medicine, molecular interactions, and therapeutic targets. RNA detection, miRNA detection, and chronic disease research are other growing applications. The market's growth is further fueled by healthcare expenditure and the need for analytical solutions. Mass spectrometry (MS), refractive index (RI), and differential scanning calorimetry (DSC) are alternative technologies used in conjunction with LFD. AuNPs, bioreceptors, signal enhancement, and on-chip purification are essential components of LFD systems.
    • The market's future lies in single-cell analysis, proteomics, genomics, and biomarkers. In conclusion, the LFD market In the US is experiencing significant growth due to its ability to provide sensitive and efficient analysis of biomolecular interactions, biomarkers, and therapeutic targets. Despite challenges, companies continue to innovate and improve the technology to meet the demands of various industries. The future of LFD lies in its ability to provide valuable insights into complex biological systems and contribute to the development of new drugs and personalized medicine.

      • Exclusive Customer Landscape

      The label-free detection (lfd) market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the label-free detection (lfd) market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

      Label-Free Detection (LFD) Market Share by Geography

       Customer Landscape

      Key Companies & Market Insights

      Companies are implementing various strategies, such as strategic alliances, label-free detection (lfd) market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

      Affinite Instruments - The Seahorse XF Analyzers represent the company's label-free detection (LFD) system offering. This technology enables real-time, high-throughput analysis of cellular metabolism and signaling pathways without requiring labeled probes. LFD is a valuable tool for researchers in various fields, including oncology, immunology, and neuroscience, to gain insights into cellular processes and identify potential therapeutic targets. The Seahorse XF Analyzers utilize a unique microplate-based approach to measure metabolic parameters, such as oxygen consumption rate, extracellular acidification rate, and ATP production, providing a comprehensive understanding of cellular metabolism. The label-free nature of the technology offers several advantages, including reduced experimental time, increased assay flexibility, and the ability to analyze primary cells and intact tissues without the need for labeling.

      The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

      • Affinite Instruments
      • Agilent Technologies Inc.
      • AMETEK Inc.
      • Attana
      • Bio Rad Laboratories Inc.
      • BioNavis Ltd.
      • BiOptix Analytical LLC
      • Bruker Corp.
      • Corning Inc.
      • Danaher Corp.
      • General Electric Co.
      • HORIBA Ltd.
      • OLS OMNI Life Science GmbH and Co. KG
      • Perkin Elmer Inc.
      • Sartorius AG
      • Spectris Plc
      • SYMCEL
      • Thermo Fisher Scientific Inc.
      • Waters Corp.
      • Wyatt Technology Corp.

      Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

      Research Analyst Overview

      Label-free detection (LFD) is an innovative technology that has gained significant attention in various fields, including drug discovery, biotechnology, applied chemistry, and biological sciences. This technology enables real-time analysis of biomolecular interactions, providing valuable insights into binding kinetics and biomarker discovery. LFD techniques, such as optical methods, offer several advantages over traditional labeling methods. They allow for the detection of native proteins and bioreceptors without the need for labeling, which can be time-consuming and costly. Moreover, LFD methods offer high sensitivity and signal enhancement, making them suitable for applications in clinical research, pharmaceutical development, and biomedical research. The application of label-free detection in drug discovery and development is particularly noteworthy.

      LFD techniques enable the screening of large libraries of compounds for potential therapeutic targets, offering a more efficient and cost-effective approach compared to traditional methods. Furthermore, LFD methods can be used to monitor biomolecular interactions in real-time, providing valuable information on binding kinetics and affinity constants. One of the most commonly used LFD techniques is surface plasmon resonance (SPR), which measures the refractive index changes that occur when a biomolecule binds to a sensor surface. Other techniques, such as differential scanning calorimetry (DSC) and mass spectrometry (MS), are also used for label-free detection of biomolecules. The use of LFD methods in clinical research and diagnostics is another promising area.

      For instance, LFD techniques can be used for the detection of RNA and miRNA, providing valuable information on gene expression and regulation. Moreover, LFD methods can be used for the detection of biomarkers associated with chronic diseases, enabling early diagnosis and personalized medicine. The increasing demand for analytical solutions In the biopharmaceutical industry is driving the growth of the label-free detection market. The ability of LFD methods to offer high sensitivity, real-time analysis, and the ability to detect native proteins and biomolecules makes them an attractive alternative to traditional labeling methods. Moreover, the use of LFD methods in high-throughput screening and on-chip purification offers significant advantages in terms of time and cost savings.

      These advantages are particularly important In the context of the increasing healthcare expenditure and the need for efficient and cost-effective solutions In the biopharmaceutical industry. In conclusion, the label-free detection market is poised for significant growth, driven by the increasing demand for analytical solutions In the biopharmaceutical industry. LFD techniques offer several advantages over traditional labeling methods, including high sensitivity, real-time analysis, and the ability to detect native proteins and biomolecules. The applications of LFD methods in drug discovery, clinical research, and diagnostics are particularly noteworthy, offering significant benefits in terms of efficiency, cost savings, and improved diagnostic accuracy.

      Market Scope

      Report Coverage

      Details

      Page number

      165

      Base year

      2023

      Historic period

      		 2018-2022

      Forecast period

      2024-2028

      Growth momentum & CAGR

      Accelerate at a CAGR of 7.1%

      Market growth 2024-2028

      USD 324.8 million

      Market structure

      Fragmented

      YoY growth 2023-2024(%)

      6.5

      Key countries

      US, Germany, China, UK, and France

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Request Free Sample

      What are the Key Data Covered in this Label-Free Detection (LFD) Market Research and Growth Report?

      • CAGR of the Label-Free Detection (LFD) industry during the forecast period
      • Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
      • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
      • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
      • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
      • Thorough analysis of the market’s competitive landscape and detailed information about companies
      • Comprehensive analysis of factors that will challenge the label-free detection (lfd) market growth of industry companies

      We can help! Our analysts can customize this label-free detection (lfd) market research report to meet your requirements.

      Get in touch

       

      Table of Contents not available.

      Research Methodology

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      INFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases

      DATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts

      REPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape

      Interested in this report?

      Get your sample now to see our research methodology and insights!

      Download Now

      Frequently Asked Questions

      Label-Free Detection (LFD) market growth will increase by $ 324.8 mn during 2024-2028.

      The Label-Free Detection (LFD) market is expected to grow at a CAGR of 7.1% during 2024-2028.

      Label-Free Detection (LFD) market is segmented by End-user( Pharmaceutical and biotechnology companies, Contract research organizations (CROs), Academic and research institutes) Product( Biochemical assays, Cell-based assays)

      Affinite Instruments, Agilent Technologies Inc., AMETEK Inc., Attana, Bio Rad Laboratories Inc., BioNavis Ltd., BiOptix Analytical LLC, Bruker Corp., Corning Inc., Danaher Corp., General Electric Co., HORIBA Ltd., OLS OMNI Life Science GmbH and Co. KG, Perkin Elmer Inc., Sartorius AG, Spectris Plc, SYMCEL, Thermo Fisher Scientific Inc., Waters Corp., Wyatt Technology Corp. are a few of the key vendors in the Label-Free Detection (LFD) market.

      North America will register the highest growth rate of 36% among the other regions. Therefore, the Label-Free Detection (LFD) market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

      US, Germany, China, UK, France

      • Rise in drug discovery programsThe increasing incidence of chronic diseases is the driving factor this market.
      • such as respiratory diseases is the driving factor this market.
      • chronic kidney diseases is the driving factor this market.
      • and leukemia is the driving factor this market.
      • have contributed to the rise in drug discovery. Various drug discovery programs are organized by several academic and research institutes globally. Drug development helps in testing the toxicity of the drug and its efficacy at the target tissue or organ in a patient. The pharmaceutical industry also witnesses an increase in partnerships between academic research institutes and major pharmaceutical/ biotechnology companies. In February 2022 is the driving factor this market.
      • Corning highlighted its latest technologies that support the advancement of 3D cell culture and drug discovery at the Society for Laboratory Automation and Screening (SLAS) conference 2022. Similarly is the driving factor this market.
      • various other companies are involved in the drug discovery program. Oncodesign is one of the drug discovery programs that helps in the discovery of novel protein kinase inhibitors. This is regarded as the next-generation cancer therapy in the pharmaceutical industry.The increase in drug discovery programs by academic institutes and pharmaceutical companies positively impacts the growth of the global LFD market. Various vendors offer LFD for drug discovery; for instance is the driving factor this market.
      • Corning offers LFD for new drug targets. As LFD enables ease of detection and eliminates tagging of testing samples is the driving factor this market.
      • the total expenditure of drug testing and enhancement is reduced. Thus is the driving factor this market.
      • the increasing drug discovery programs and application of LFD in drug discovery will drive the growth of the market in focus during the forecast period. is the driving factor this market.

      The Label-Free Detection (LFD) market vendors should focus on grabbing business opportunities from the Pharmaceutical and biotechnology companies segment as it accounted for the largest market share in the base year.